Related Experiment Video
Updated: Jan 18, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Lactylation as a metabolic-epigenetic nexus in epilepsy: Mechanisms and therapeutic implications
Ting Chen1, Sha Wen2, Ling Gong3
1Department of Neurology, The Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Zunyi 563000, Guizhou, PR China; The Affiliated Jinyang Hospital of Guizhou Medical University, No. 547 Jinyang South Road, Guiyang 550081, Guizhou, PR China; Key Laboratory of Brain Function and Brain Disease Prevention and Treatment of Guizhou Province, Zunyi 563000, Guizhou, PR China.
Abstract:
Lactylation is a novel post-translational modification (PTM) mediated by lactate, which dynamically regulates protein functions and gene expression by covalently attaching lactate groups to lysine residues. Recent studies have shown that abnormal lactate metabolism not only contributes to the pathogenesis of epilepsy through microenvironment acidification but also influences neuroinflammation, energy metabolism imbalance, neurotransmitter dysregulation, synaptic plasticity, and epigenetic regulation via lactylation. This positions lactylation as a critical metabolic-epigenetic intersection in the pathological mechanisms of epilepsy. This review systematically summarizes the molecular mechanisms of lactylation and its potential roles in epilepsy, while exploring intervention strategies targeting lactylation to provide new perspectives for epilepsy treatment.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Long-term Depression
Antiepileptic Drugs: Glutamate Antagonists

